Skip to content

Evaluation of Brain Health and Surgical Efficacy in Patients With Carotid Artery Stenosis

Research on Changes of Cerebral Vascular Morphology and Cognitive Function in Patients With Carotid Artery Stenosis Before and After Surgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05848921
Enrollment
100
Registered
2023-05-08
Start date
2023-05-01
Completion date
2025-12-31
Last updated
2023-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid Artery Stenosis, Image

Keywords

Carotid Artery Stenosis, MRI Imaging

Brief summary

The purpose of this study is to explore the relationship between the recovery of cerebrovascular morphology and cognitive function before and after surgical treatment in patients with carotid artery stenosis and their preoperative cardiac health status. And combined with preoperative cognitive status, serum markers, and cardiovascular health evaluation indicators, evaluate and predict the possibility of postoperative neurodegenerative diseases and the level of cerebrovascular health in patients.

Detailed description

The aim of this study is to evaluate the brain health status and surgical efficacy of patients with carotid artery stenosis. Firstly, investigate whether hemodynamic parameters such as blood flow reserve fraction at the carotid artery stenosis site are correlated with white matter hyperintensities and cerebral vascular morphological changes in elderly patients with normal cognition and mild cognitive impairment; Then, when the blood flow of carotid artery has been improved after surgery, compare the cerebrovascular health of patients before surgery and the way of cerebral vascular reconstruction; Combined with the postoperative neuropsychological cognitive test to explore the postoperative cognitive recovery of patients, and combined with the postoperative imaging data and the biomarker in the blood of patients at various stages, to explore the way of cerebral vascular reconstruction and changes in brain structure and function of different groups of patients behind cognitive changes.

Interventions

Imaging data were collected in a strong magnetic field

Multi dimensional neuropsychological test

Sponsors

Xi'an Jiaotong University
CollaboratorOTHER
The 2rd School of Medicine,WMU/The 2rd Affiliated Hospital and Yuying Children's Hospiyal of WMU
CollaboratorUNKNOWN
Nanjing University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged over 50 years old; * Conscious and capable of completing neuropsychological scales * Clinical detection of carotid artery stenosis requires surgical treatment; * Compliant with carotid artery stenting or carotid endarterectomy surgical standards * Individuals with normal cognition and mild cognitive impairment

Exclusion criteria

* Degree of vascular blockage in other intracranial segments ≥ 50% * Have a history of mental illness, nervous system disease (such as stroke) or brain injury with loss of consciousness for more than five minutes; * Neurological and psychiatric disorders unrelated to AD (schizophrenia, depression, etc.), post-traumatic stress disorder, obsessive-compulsive disorder, multiple sclerosis, amyotrophic lateral sclerosis) * Have a history of alcohol or drug abuse * There are contraindications for magnetic resonance imaging examination * Those with significant organ dysfunction such as lung, liver, and kidney; * Patients with intracranial tumors, infectious diseases, and blood system diseases; * Participating in other clinical studies at the same time

Design outcomes

Primary

MeasureTime frameDescription
Change of brain volume before and after treatmentbefore operation; 3-10 Days after operation; 1 month; 6-12months]The change of brain volume (mm3) are evaluated by structural 3DT1 weighted MRI. Freesurfer software is used to get the measured value of the volume.
Change of cerebrovascular morphology before and after treatmentbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of Cerebral vessel density, caliber and tortuosity, brain white matter hyperintensity lesion count
Change of brain function connectivity before and after operationbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of brain functional connectivity intensity are evaluated by rest stage functional MRI. DPABI software based on MATLAB is used to get the measured the matrix value of functional connectivity.

Secondary

MeasureTime frameDescription
Change of executive functions before and after operation evaluated by Trail-Making Test Part Abefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of executive functions are first evaluated by Trail-Making Test Part A test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.
Change of executive functions before and after operation evaluated by Digit Symbol Coding scorebefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of executive functions are second evaluated by Digit Symbol Coding score. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 56.53 ± 20.17. The higher scores mean a better outcome.
Change of working memory before and after operation evaluated by Forward Digit Spanbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of working memory is first evaluated by Forward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 7.75±1.47. The higher scores mean a better outcome.
Change of serum marker concentration before and after operationbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of serum marker concentration is evaluated by inflammatory cytokine.
Change of language function before and after operation evaluated by Language Fluency testbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of language function is evaluated by Language Fluency test. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 19.43±4.81. The higher scores mean a better outcome.
Change of executive functions before and after operation evaluated by Clock Drawing Testbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of executive functions is evaluated by Backward Digit Span. The minimum value is 0 , the maximum value is 4.
Change of executive functions before and after operation evaluated by Trail-Making Test Part Bbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of executive functions are first evaluated by Trail-Making Test Part B test. The minimum value is 0 , and the maximum value is 30. This test has no clear maximum and minimum values. If the test completion time exceeds 79 seconds, it means the outcome is abnormal. The higher scores mean a worse outcome.It is a supplement to Trail-Making Test Part A, which is optional for patients who are not familiar with the English alphabetical order
Change of working memory before and after operation evaluated by Backward Digit Spanbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of working memory is second evaluated by Backward Digit Span. The minimum value is 0 , and the maximum value is not clear. The normal range of results is 5.36±1.91. The higher scores mean a better outcome.
Change of plasma marker concentration before and after operationbefore operation; 3-10 Days after operation; 1 month; 6-12monthsThe change of plasma marker concentration is evaluated by neurofilament light chain(NFL) protein extracted from plasma.
Brain evaluate basic cognition before operationbefore operationBasic cognition is evaluated by Mini-mental State Examination (MMSE) and Clinical Dementia Rating (CDR) . For MMSE , The minimum value is 0 , and the maximum value is 30. The higher scores mean a better outcome. For CDR , the results are represented by scores of 0,0.5,1,2,3, and the degree of cognitive impairment is classified as normal, suspicious, mild, moderate, and severe

Countries

China

Contacts

Primary ContactBo Yin, phD
76yinbo@163.com0086-13857773745
Backup ContactLijun Bai, phD
bailijun@xjtu.edu.cn0086-15129034948

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026